Early thymopentin pilot series in AIDS and symptomatic HIV
Study involving people · 1985
- What was studied
- Three uncontrolled groups of 5, 6 and 5 described by the Belgian team.
- Main finding
- Advanced AIDS, 50 mg slow IV (n=5) · The investigators reported no immunological or clinical improvement.
Reported findings and study design
Reported findings
Five with AIDS received 50 mg by slow IV infusion three times weekly. Six with earlier symptomatic disease received 50 mg IV three times weekly as a bolus for one month and then as a slow infusion for one month. A further five received 15 mg subcutaneously three times weekly.
Population or model Three uncontrolled groups of 5, 6 and 5 described by the Belgian team.
Dose, route and schedule
Five with AIDS received 50 mg by slow IV infusion three times weekly. Six with earlier symptomatic disease received 50 mg IV three times weekly as a bolus for one month and then as a slow infusion for one month. A further five received 15 mg subcutaneously three times weekly.
Protocol source ↗ · Original indexed abstract of three pilot series.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Advanced AIDS, 50 mg slow IV (n=5) | The investigators reported no immunological or clinical improvement. | |
| Earlier symptomatic disease, IV (n=6) | Immune measures and clinical status improved during the slow-infusion period. The response reportedly persisted for a mean of eight months. The abstract does not give individual responder counts. | |
| Earlier symptomatic disease, 15 mg subcutaneous (n=5) | 1/5 had reported clinical and immunological improvement. |
These were uncontrolled pilots with sequential treatment in the six-person group. The same team published earlier reports in 1983 and 1984. Participant overlap with those reports is unresolved, so their sample sizes cannot be added.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- These were uncontrolled pilots with sequential treatment in the six-person group. The same team published earlier reports in 1983 and 1984. Participant overlap with those reports is unresolved, so their sample sizes cannot be added.
Related publications may describe some of the same participants or experiments.
Source details
Original indexed abstract of three pilot series.
Sources checked
Added to the library
Citation
N. Clumeck, S. Cran, P. Van de Perre, F. Mascart-Lemone, J. Duchateau, K. Bolla. Early thymopentin pilot series in AIDS and symptomatic HIV Survey of Immunologic Research 4(Suppl 1), 58–62
Study source ↗ · DOI 10.1007/BF02919057 · Bibliography entry · Link to this summary